Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Sermorelin structure

Sermorelin

Growth Hormone
Phase 3 Research
70%
Low Risk
1/5

Dosing Protocol

Typical Dose 300 mcg
Range 100 - 500 mcg
Maintenance 300 mcg daily

Pharmacokinetics

Half-Life 12 min
Onset 5 min
Peak 10 min
Duration 1.0 hrs
Bioavailability 90%
Primary Route Subcutaneous

Administration

Routes Subcutaneous
Injection Sites Abdomen, Thigh, Deltoid
Needle Gauge 29-31G
Syringe Type Insulin
Timing Before Bed, Fasted

Reconstitution

Diluent Bacteriostatic Water
Volume 3 mL
Concentration 1000 mcg/mL
Stability 21 days refrigerated
Vial Sizes 3, 6, 9 mg

Special Instructions

Previously FDA-approved. Best taken before bed on empty stomach for natural GH pulse enhancement.